Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07661550 · ClinicalTrials.gov registry record · NA
Prevention of Postpartum Smoking Relapse and Related Health Consequences by Breastfeeding Promotion
A NA study, sponsored by State University of New York at Buffalo.
- Recruiting
- Registry status
- NA
- Development phase
- 280
- Enrollment target
NCT07661550: Recruiting NA study, sponsored by State University of New York at Buffalo.
NCT07661550 is a NA study that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 280 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07661550, a NA study, is actively recruiting participants, sponsored by State University of New York at Buffalo.
- RECRUITING
- Registry status
- NA
- Development phase
- 280 participants
- Enrollment target
Study Summary
The objective of this randomized controlled trial is to examine the efficacy of a new intervention to prevent postpartum smoking relapse and related health consequences through breastfeeding promotion. After the pre-test, ex-smokers who are still abstinent from smoking will be randomized into either the breastfeeding intervention or the attention placebo control group. The outcomes are postpartum smoking relapse, breastfeeding practices, and maternal and child health.
Interventions
- BEHAVIORAL Breastfeeding promotion
- BEHAVIORAL Attention placebo control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2026-01-01 |
| Est. Completion | 2031-07-31 |
| Phase | NA |
What NCT07661550 shows while recruiting
NCT07661550 is an interventional study that assigns participants to a tested intervention. The registered 280 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 2 interventions - of which Breastfeeding promotion is the first listed.
NCT07661550 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07661550 about?
NCT07661550 is a clinical study titled "Prevention of Postpartum Smoking Relapse and Related Health Consequences by Breastfeeding Promotion". The objective of this randomized controlled trial is to examine the efficacy of a new intervention to prevent postpartum smoking relapse and related health consequences through breastfeeding promotion. After the pre-test, ex-smokers who are still abstinent from smoking will be randomized into either...
What is the current status of trial NCT07661550?
This trial is currently recruiting. It is a NA study. The enrollment target is 280 participants. The study started on 2026-01-01. Estimated completion is 2031-07-31.
What interventions are being tested in trial NCT07661550?
The interventions under investigation include: Breastfeeding promotion (BEHAVIORAL), Attention placebo control (BEHAVIORAL).
Who is sponsoring clinical trial NCT07661550?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07661550's enrollment target sits among peer trials
280 380th of 2000 higher than 1,620 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04084730 · 280 participants · Phase 2
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
- NCT04518657 · 280 participants · NA
Internet-Delivered Lifestyle Physical Activity Intervention for Cognitive Processing Speed in Multiple Sclerosis
- NCT04634916 · 280 participants · NA
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
- NCT04829617 · 280 participants · NA
Promoting Well-being and Health in Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI